Profil
Robert Berman was the founder of Biohaven Pharmaceuticals, Inc., which was founded in 2013, where he held the title of Chief Medical Officer from 2013 to 2019.
Currently, he is an Independent Director at Social Capital Suvretta Holdings Corp.
II, where he started in 2022.
Dr. Berman received his undergraduate degree from Yale University and another undergraduate degree from Icahn School of Medicine at Mount Sinai in 1990.
Postes actifs de Robert Berman
| Sociétés | Poste | Début |
|---|---|---|
| SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. II | Directeur/Membre du Conseil | 29/06/2022 |
Anciens postes connus de Robert Berman
| Sociétés | Poste | Fin |
|---|---|---|
Biohaven Pharmaceuticals, Inc.
Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization | Fondateur | 01/01/2019 |
Formation de Robert Berman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biohaven Pharmaceuticals, Inc.
Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization | Commercial Services |
Social Capital Suvretta Holdings Corp. II
Social Capital Suvretta Holdings Corp. II Financial ConglomeratesFinance Operates as blank check company | Finance |
















